Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
- 27 March 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 100 (7), 933-939
- https://doi.org/10.1002/bjs.9112
Abstract
Background Neoadjuvant chemoradiotherapy (CRT) has been proven to increase local control in rectal cancer, but the optimal interval between CRT and surgery is still unclear. The purpose of this study was to analyse the influence of variations in clinical practice regarding timing of surgery on pathological response at a population level. Methods All evaluable patients who underwent preoperative CRT for rectal cancer between 2009 and 2011 were selected from the Dutch Surgical Colorectal Audit. The interval between radiotherapy and surgery was calculated from the start of radiotherapy. The primary endpoint was pathological complete response (pCR; pathological status after chemoradiotherapy (yp) T0 N0). Results A total of 1593 patients were included. The median interval between radiotherapy and surgery was 14 (range 6–85, interquartile range 12–16) weeks. Outcome measures were calculated for intervals of less than 13 weeks (312 patients), 13–14 weeks (511 patients), 15–16 weeks (406 patients) and more than 16 weeks (364 patients). Age, tumour location and R0 resection rate were distributed equally between the four groups; significant differences were found for clinical tumour category (cT4: 17·3, 18·4, 24·5 and 26·6 per cent respectively; P = 0·010) and clinical metastasis category (cM1: 4·4, 4·8, 8·9 and 14·9 per cent respectively; P < 0·001). Resection 15–16 weeks after the start of CRT resulted in the highest pCR rate (18·0 per cent; P = 0·013), with an independent association (hazard ratio 1·63, 95 per cent confidence interval 1·20 to 2·23). Results for secondary endpoints in the group with an interval of 15–16 weeks were: tumour downstaging, 55·2 per cent (P = 0·165); nodal downstaging, 58·6 per cent (P = 0·036); and (near)‐complete response, 23·2 per cent (P = 0·124). Conclusion Delaying surgery until the 15th or 16th week after the start of CRT (10–11 weeks from the end of CRT) seemed to result in the highest chance of a pCR.Keywords
This publication has 25 references indexed in Scilit:
- Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III TrialJournal of Clinical Oncology, 2011
- Neoadjuvant Therapy in Rectal CancerDiseases of the Colon & Rectum, 2011
- Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosisBritish Journal of Surgery, 2008
- Optimal Surgery Time After Preoperative Chemoradiotherapy for Locally Advanced Rectal CancersAnnals of Surgery, 2008
- An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal CancerAnnals of Surgical Oncology, 2008
- Effect of time interval between surgery and preoperative chemoradiotherapy with 5‐fluorouracil or 5‐fluorouracil and oxaliplatin on outcomes in rectal cancerJournal of Surgical Oncology, 2007
- Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancerThe American Journal of Surgery, 2006
- Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancerColorectal Disease, 2006
- Rate of Pathologic Complete Response With Increased Interval Between Preoperative Combined Modality Therapy and Rectal Cancer ResectionDiseases of the Colon & Rectum, 2004
- Longer Time Interval Between Completion of Neoadjuvant Chemoradiation and Surgical Resection Does Not Improve Downstaging of Rectal CarcinomaDiseases of the Colon & Rectum, 2003